224 related articles for article (PubMed ID: 19712708)
1. To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition.
Jacobsen JA; Major Jourden JL; Miller MT; Cohen SM
Biochim Biophys Acta; 2010 Jan; 1803(1):72-94. PubMed ID: 19712708
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent and selective MMP-13 inhibitors.
Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.
Nuti E; Tuccinardi T; Rossello A
Curr Pharm Des; 2007; 13(20):2087-100. PubMed ID: 17627541
[TBL] [Abstract][Full Text] [Related]
4. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors.
Puerta DT; Cohen SM
Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177
[TBL] [Abstract][Full Text] [Related]
5. Zinc-binding groups modulate selective inhibition of MMPs.
Agrawal A; Romero-Perez D; Jacobsen JA; Villarreal FJ; Cohen SM
ChemMedChem; 2008 May; 3(5):812-20. PubMed ID: 18181119
[TBL] [Abstract][Full Text] [Related]
6. A new role for old ligands: discerning chelators for zinc metalloproteinases.
Jacobsen FE; Lewis JA; Cohen SM
J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of leukotriene A4 hydrolase in complex with kelatorphan, implications for design of zinc metallopeptidase inhibitors.
Tholander F; Roques BP; Fournié-Zaluski MC; Thunnissen MM; Haeggström JZ
FEBS Lett; 2010 Aug; 584(15):3446-51. PubMed ID: 20609366
[TBL] [Abstract][Full Text] [Related]
8. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
Puerta DT; Lewis JA; Cohen SM
J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
[TBL] [Abstract][Full Text] [Related]
9. A practical approach to docking of zinc metalloproteinase inhibitors.
Hu X; Balaz S; Shelver WH
J Mol Graph Model; 2004 Mar; 22(4):293-307. PubMed ID: 15177081
[TBL] [Abstract][Full Text] [Related]
10. Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.
Rahman F; Wushur I; Malla N; Åstrand OAH; Rongved P; Winberg JO; Sylte I
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011288
[TBL] [Abstract][Full Text] [Related]
11. A bioinorganic perspective on matrix metalloproteinase inhibition.
Puerta DT; Cohen SM
Curr Top Med Chem; 2004; 4(15):1551-73. PubMed ID: 15579096
[TBL] [Abstract][Full Text] [Related]
12. Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Li X; Liang X; Jin K; Cao J; Xu W
Bioorg Med Chem Lett; 2013 Sep; 23(17):4948-52. PubMed ID: 23860593
[TBL] [Abstract][Full Text] [Related]
13. Phosphinic peptides as potent inhibitors of zinc-metalloproteases.
Georgiadis D; Dive V
Top Curr Chem; 2015; 360():1-38. PubMed ID: 25370521
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.
Yan YL; Miller MT; Cao Y; Cohen SM
Bioorg Med Chem Lett; 2009 Apr; 19(7):1970-6. PubMed ID: 19261472
[TBL] [Abstract][Full Text] [Related]
15. Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
Kalinin DV; Wagner S; Riemann B; Hermann S; Schmidt F; Becker-Pauly C; Rose-John S; Schäfers M; Holl R
J Med Chem; 2016 Oct; 59(20):9541-9559. PubMed ID: 27696839
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
17. Investigating chelating sulfonamides and their use in metalloproteinase inhibitors.
Tanakit A; Rouffet M; Martin DP; Cohen SM
Dalton Trans; 2012 Jun; 41(21):6507-15. PubMed ID: 22411188
[TBL] [Abstract][Full Text] [Related]
18. Structural studies of BmooMPalpha-I, a non-hemorrhagic metalloproteinase from Bothrops moojeni venom.
Akao PK; Tonoli CC; Navarro MS; Cintra AC; Neto JR; Arni RK; Murakami MT
Toxicon; 2010; 55(2-3):361-8. PubMed ID: 19706302
[TBL] [Abstract][Full Text] [Related]
19. Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors.
Zhong HA; Arbiser J; Bowen JP
Curr Pharm Des; 2013; 19(26):4701-13. PubMed ID: 23260023
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
